Cardiac function and hematocrit level
- 30 April 1995
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 25 (4), S3-S7
- https://doi.org/10.1016/0272-6386(95)90673-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992
- Long-Term Myocardial Effects of Correction of Anemia With Recombinant Human Erythropoietin in Aged Patients on HemodialysisAmerican Journal of Kidney Diseases, 1992
- Haemodynamic Effect of Recombinant Human Erythropoietin on Hypotensive Haemodialysis PatientsNephrology Dialysis Transplantation, 1991
- Hemodynamic Changes in Hemodialyzed Patients during Treatment with Recombinant Human ErythropoietinNephron, 1991
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinThe Lancet, 1990
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in JapanThe International Journal of Artificial Organs, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987